Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07071532
PHASE1
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.
Official title: A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of ABBV-932 in Healthy Adult Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-07-15
Completion Date
2025-11
Last Updated
2025-09-10
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
ABBV-932
Oral Capsule
DRUG
Itraconazole
Oral Capsule
Locations (1)
Acpru /Id# 276951
Grayslake, Illinois, United States